Blume Capital Management’s Labcorp LH Stock Holding History

Blume Capital Management’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1	Closed	-$233	–	508
2025 Q1	$233	Buy	+1	New	+$243	﹤0.01%	430

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Diamond Hill Capital Management Columbus, Ohio $16B AUM 4.15% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Blume Capital Management's LH Position: Q2 2025 in Review

Blume Capital Management sold out of Labcorp (LH) in Q2 2025, closing a stake of 1 share — an estimated $233 sold.

Blume Capital Management first reported a position in LH in Q1 2025 and held it in 1 quarter. The position peaked at $233 in Q1 2025. 973 funds tracked by Wall St. Rank hold LH as of Q2 2025.

Blume Capital Management reported no remaining Labcorp position as of Q2 2025 after selling out during the quarter.
Blume Capital Management sold 1 Labcorp share in Q2 2025, an estimated $233.
Blume Capital Management first reported a position in Labcorp in Q1 2025 and held it in 1 quarter.
Blume Capital Management's Labcorp position peaked at $233 in Q1 2025.
973 funds tracked by Wall St. Rank held Labcorp as of Q2 2025.

Based on Blume Capital Management's 13F filing for Q2 2025, filed 30 Jul 2025.